Clinical Studies
-
Probiotic Study in Dogs
OpenWe are studying a novel live probiotic product typically found in the gut of healthy dogs to evaluate the ability of this probiotic to resolve diarrhea in dogs.
Study Details -
Canine Acute Onset Pancreatitis Study
OpenThis study will evaluate the safety and effectiveness of a newly proposed anti-inflammatory drug in dogs experiencing mild acute onset pancreatitis (AOP) symptoms.
Study Details -
Lung Tumor Fluid Dynamics Study
OpenCurrent chemotherapy treatments involve a direct injection into the tumor. We would like to use surgically removed lung tissue to better understand how drugs behave when they are injected into lung tumors in dogs, as well as humans, with lung tumors.
Study Details -
Methylnaltrexone (MNTX) Clinical Study
OpenThis study seeks to define the rate at which methylnaltrexone (MNTX) is metabolized in dogs following intravenous administration. Postoperative regurgitation is a common side effect of general anesthesia. The opioid-inhibiting effects of MNTX block the risk of opioid-related complications, without reducing pain control and pain management.
Study Details -
Necrotizing Meningoencephalitis Study for Pugs (SEEP/STEEP)
OpenNecrotizing Meningoencephalitis in Pugs (PDE) is a devastating disease. Clinical signs include seizures, circling, cognitive changes, and visual deficits. Our goal is to identify neurological abnormalities in Pugs with high genomic risk for PDE before the onset of the above-mentioned advanced clinical signs.
Study Details -
Evaluation of Liver Protectants for Xylitol Toxicity in Dogs
OpenXylitol is an artificial sweetener commonly found in sugar-free gum. Although safe for humans, xylitol is highly toxic to dogs. This study will compare the liver protective capacity of two veterinary liver protectant products in dogs suffering from xylitol toxicity.
Study Details -
Oral Melanoma Study in Dogs
OpenThis clinical trial will evaluate the effectiveness of a novel investigational product for the treatment of oral melanoma in dogs.
Study Details -
Dysbiosis Enhancing Linkage Towards Association with Canine Osteosarcoma (DEL-TACO Lite)
OpenThis study aims to determine whether or not canine patients diagnosed with canine osteosarcoma (OSA) have intestinal dysbiosis and whether treating intestinal disease improves patient outcomes.
Study Details -
Ethos Precision Medicine Umbrella Study for Hemangiosarcoma (Ethos-PUSH)
OpenIs your dog undergoing surgery for a ruptured splenic tumor? Ethos Discovery would love to have you and your dog participate in our clinical trial! We are evaluating drugs for the treatment of HSA with the goal of curing this aggressive cancer.
Study Details -
Embolization of the Splenic Artery for Thrombocytopenia (eSPAT)
ClosedImmune-mediated thrombocytopenia (ITP) is a disorder characterized by severely low platelets due to attack by white blood cells. This is often associated with bruising and occasionally severe bleeding episodes.
Study Details -
Evaluating Benefit of a Novel Intra-articular Device in Dogs With a Suspected Cruciate Ligament Tear
ClosedA new veterinary device composed of collagen and elastin particles has been developed; it is delivered via intra-articular injection and helps protect cartilage from mechanical grinding. This study seeks to validate this device as a pre-surgical management tool for dogs with cruciate disease.
Study Details -
Evaluating the Tolerability of a Novel PCNA Inhibitor in Dogs with Cancer
ClosedProliferating cell nuclear antigen (PCNA) is an important protein necessary for the repair of DNA in cells. Cancer cells express a unique type of PCNA (termed caPCNA) which is only found at small quantities in non-cancer cells.
Study Details
